Susquehanna International Group, LLP Adma Biologics, Inc. Transaction History
Susquehanna International Group, LLP
- $560 Billion
- Q3 2024
A detailed history of Susquehanna International Group, LLP transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 61,688 shares of ADMA stock, worth $1.05 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
61,688
Previous 77,639
20.55%
Holding current value
$1.05 Million
Previous $868,000
42.05%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding ADMA
# of Institutions
323Shares Held
190MCall Options Held
917KPut Options Held
91.6K-
Black Rock Inc. New York, NY18.6MShares$316 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.1MShares$307 Million0.01% of portfolio
-
State Street Corp Boston, MA13MShares$220 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.6MShares$214 Million0.05% of portfolio
-
Morgan Stanley New York, NY8.6MShares$146 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.33B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...